Log in
Enquire now
‌

US Patent 9868760 Protein purification

Patent 9868760 was granted and assigned to Genentech on January, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Genentech
Genentech
0
Current Assignee
Genentech
Genentech
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
98687600
Patent Inventor Names
Jefferson C. Emery0
Paul J. McDonald0
Rhona O'Leary0
Date of Patent
January 16, 2018
0
Patent Application Number
142184450
Date Filed
March 18, 2014
0
Patent Citations Received
‌
US Patent 11992529 Adjuvant treatment of HER2-positive breast cancer
0
‌
US Patent 12128103 Adjuvant treatment of HER2-positive breast cancer
0
‌
US Patent 12110341 Composition comprising antibody that binds to domain II of HER2 and acidic variants thereof
0
‌
US Patent 11654105 Subcutaneous HER2 antibody formulations
0
‌
US Patent 11655305 Treatment of metastatic breast cancer
0
Patent Primary Examiner
‌
Maury A Audet
0
Patent abstract

A method for purifying a polypeptide by ion exchange chromatography is described in which a gradient wash is used to resolve a polypeptide of interest from one or more contaminants.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9868760 Protein purification

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.